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Inﬂammatory myoﬁbroblastic tumor (IMT) is a mesenchymal tumor that can arise from anywhere in the
body. Anaplastic lymphoma kinase (ALK) gene rearrangements, most often resulting in the tropomyosin
3 (TPM3)-ALK fusion gene, are the main causes of IMT. However, the mechanism of malignant trans-
formation in IMT has yet to be elucidated. The purpose of this study was to clarify the role of the TPM3
region in the transformation of IMT via TPM3-ALK. Lentivirus vectors containing a TPM3-ALK fusion gene
lacking various lengths of TPM3 were constructed and expressed in HEK293T and NIH3T3 cell lines.
Focus formation assay revealed loss of contact inhibition in NIH3T3 cells transfected with full-length
TPM3-ALK, but not with ALK alone. Blue-native polyacrylamide gel electrophoresis (BN-PAGE)
revealed that TPM3-ALK dimerization increased in proportion to the length of TPM3. Western blot
showed phosphorylation of ALK, ERK1/2, and STAT3 in HEK293T cells transfected with TPM3-ALK. Thus,
the coiled-coil structure of TPM3 contributes to the transforming ability of the TPM3-ALK fusion protein,
and longer TPM3 region leads to higher dimer formation.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Inﬂammatory myoﬁbroblastic tumor (IMT) is a rare disease that
is deﬁned as a true neoplasm of myoﬁbroblastic spindle cells
accompanied by a variable inﬂammatory inﬁltrate of plasma cells,
eosinophils, and lymphocytes, and occurs in various organs [1].
Since the ﬁrst report of anaplastic lymphoma kinase (ALK) gene
rearrangement caused by chromosomal translocation by Grifﬁn
et al. [2] and the detection of the tropomyosin 3 (TPM3)-ALK fusion
gene by Lawrence et al. [3], about half of all IMT cases have been
found to exhibit ALK gene rearrangements [4]. As fusion gene
partners of ALK, TPM3, TPM4, CTLC, ATIC, CARS, RANBP2, SEC31L1,BN-PAGE, blue-native poly-
t protein; IMT, inﬂammatory
u, Tokyo 113-8655, Japan.
Inc. This is an open access article uand PPFIBP1 have so far been reported in patients with IMT, with
TPM3 being the most frequent [4,5].
These fusion genes have been described to provide malignant
potential through two mechanisms: 1) the promoter of the up-
stream fusion partner promotes the constitutive transcription of
the fusion gene in cells that originally express small amounts of the
carboxyl-terminal gene; and 2) the dimerization domain of the
upstream fusion partner induces the dimerization of the fusion
protein, causing the auto-phosphorylation of the carboxyl-terminal
gene [4,6]. However, few reports have demonstrated the dimer-
ization of fusion proteins and the relationship between dimeriza-
tion and malignant potential [7,8]. The fusion partner may also
deﬁne the cellular localization of the fusion protein [6].
While ALK is normally silent in adults except in the central
nervous system, TPM3 is constitutively expressed in mesenchymal
cells. TPM3 is composed of a coiled-coil structure andmay promote
dimerization of TPM3-ALK fusion protein and may promote auto-
phosphorylation of the ALK catalytic domain. Although these two
mechanisms are presumed to lead to the generation of IMT [3,9], it
has never been shown. In the present study, we elucidated the rolender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ALK fusion protein using blue-native polyacrylamide gel electro-
phoresis (BN-PAGE).
2. Materials and methods
2.1. TPM3-ALK fusion gene cloning and lentivirus vector constructs
We obtained the TPM3-ALK fusion gene from a surgical spec-
imen of a lung inﬂammatory myoﬁbroblastic tumor from a 42 year-
old man, after obtaining written informed consent and approval
from the ethical committee of our institute (Fig. 1). The fusion gene
was gene conﬁrmed using the 50-rapid ampliﬁcation of cDNA ends
(50-RACE) technique with SMARTer® PCR cDNA Synthesis Kit ac-
cording to the manufacturer's instruction (Clontech Laboratories,
Mountain View, CA, USA). After cloning the coding sequence of the
TPM3-ALK fusion gene using pGEM-T easy Vector Systems (Prom-
ega, Madison,WI, USA) (D0), various lengths (165, 330, 495, 660 bp)
were deleted from the 50 end immediately after the ﬁrst ATG (D1,
D2, D3, D4 in Fig. 1) using an inverse PCR [10,11]. D*1 consisted of a
fusion gene lacking 165 bp of the TPM3 region from the 30 end. The
primers used for cloning were sense 50-CACCATGGCTGGGATCACC-
30 and antisense GGAAGAGAAGTGAGTGTGCGACC; and the primers
used for inverse PCR were sense 50-CAGCTGGTTGAAGAAGAGCTGG-
30 (D1), 50-CTCAAAGAAGCTAAGCACATTGCAG-30 (D2), 50-AACCT-
GAAGTGTCTGAGTGCTGCT-30 (D3), and 50-GTGTACCGCCGGAAG-
CACC-30 (D4, D*1) and antisense 50-CATGGTGAATCGAATTCCCG-30
(D1, D2, D3, D4) and 50-CTGGTCCATCAGTCTAATCTGCTCAT-30 (D*1).
All the products were ligated to FLAG-tag and incorporated into a
CSII-CMV-MCS-IRES2-Bsd lentiviral plasmid (Riken BioResource
Center, Tsukuba, Ibaraki, Japan).
2.2. Cell cultures
NIH3T3 and HEK293T cell lines were obtained from American
Type Culture Collection (Manassas, VA, USA) and Lenti-X HEK293T
cell line was purchased from Clontech Laboratories. Cells were
cultured in DMEM supplemented with 10% bovine serum (NIH3T3)
or 10% fetal bovine serum (HEK293T, Lenti-X HEK293T) and anti-
biotic-antimycotic mixed stock solution (Nakarai Tesque, Kyoto,
Japan) at 37 C in a 5% CO2 incubator. Lenti-X HEK293T was
transfected with lentiviral plasmid vectors and lipofection reagent
Hilymax (Dojindo, Kumamoto, Japan) to package lentivirus.
2.3. Protein assays
Protein was extracted from HEK293T cells 4 days after infection
with a lentivirus carrying TPM3-ALK. For BN-PAGE, protein wasFig. 1. Diagram of tropomyosin 3 (TPM3), anaplastic lymphoma kinase (ALK), TPM3-
ALK fusion gene, and TPM3-ALK lacking various lengths of the TPM3 region. Coiled-
Coil: coiled-coil structure, Ig-like: immunoglobulin-like domain, TM: transmembrane
domain, TK: tyrosine kinase domain.extracted using NativePAGE™ sample buffer (Life Technologies,
Grand Island, NY, USA) without sodium dodecyl sulfate (SDS). BN-
PAGE was performed using the NativePAGE™ Novex® Bis-Tris Gel
system (Life Technologies), according to the manufacturer's in-
structions. After transfer to a PVDF membrane, the membrane was
incubated in 8% acetate for crosslinking and in methanol to remove
Coomassie Brilliant Blue G-250. Anti-FLAG-tag antibody (1:1000;
Sigma-Aldrich, St. Louis, MO, USA) was used to detect the fusion
protein. For SDS-PAGEwithwestern blotting, the following primary
antibodies were used: anti-FLAG-tag antibody (1:1000; Sigma-
Aldrich), anti-phospho-ALK antibody (1:1000), anti-ALK antibody
(1:1000), anti-phospho-ERK1/2 antibody (1:600), anti-ERK1/2
antibody (1:1000), anti-phospho-STAT3 antibody (1:600), anti-
STAT3 antibody (1:3000; Cell Signaling Technology, Danvers, MA,
USA), and anti-b-actin antibody (1:20,000; Santa Cruz Biotech-
nology, Dallas, TX, USA).
2.4. Focus formation assay
Lentiviruses were used to infect NIH3T3 cells in the presence of
blasticidin (10 mg/mL; Sigma-Aldrich, St. Louis, MO, USA). After 6
days of exposure to blasticidin, the infected NIH3T3 cells were
seeded on a 6-well plate at 1000 cells per well, cultured in
blasticidin-free medium for 28 days, and the foci were counted.
Green ﬂuorescence protein (GFP) and mutant KRAS (G12C) vectors
were used as negative and positive controls, respectively.
3. Results
3.1. Transforming activity of TPM3-ALK requires the TPM3 region
To evaluate the transforming activity of the TPM3-ALK gene, we
transfected a lentivirus vector of the TPM3-ALK gene (D0) or theFig. 2. Focus formation assay. (A) Representative images of the focus. (B) Histogram
depicting the number of foci. The focus formation assay described above was per-
formed in triplicate. *P < 0.05, **P < 0.01.
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formation assay revealed that TPM3-ALK-transfected NIH3T3 cells
(D0) formed similar number of foci compared with mutant KRAS-
transfected cells and more foci compared with green ﬂuorescent
protein (GFP) control. Cells transfected with a TPM3-region-
deleted-fusion-gene (D4) formed only a few foci (Fig. 2). Thus, the
transforming activity of the TPM3-ALK fusion gene required the
existence of the TPM3 region.3.2. TPM3-ALK dimerization requires the coiled-coil structure of
TPM3
TPM3 is an actin ﬁlament-binding protein with a dimeric a-
helical coiled-coil structure along its entire length. The coiled-coil
structure is based on a repeated pattern of seven amino acids
with hydrophobic residues at the ﬁrst and fourth positions; this
repeated pattern is known to contribute to dimerization [12e14].
Therefore, previous reports have speculated that the TPM3-ALK
fusion gene may form dimers that contribute to the constitutive
activation of ALK and its signal cascade [3,9]. To conﬁrm this
speculation, we transfected lentivirus vectors containing TPM3-
ALK fusion genes lacking various lengths of the TPM3 coiled-coil
structure into HEK293T cells and visualized the resulting dimer-
ization using blue-native polyacrylamide gel electrophoresis (BN-
PAGE) (Fig. 3A). BN-PAGE detected TPM3-ALK dimers but no
monomers after transfecting full-length TPM3-ALK. Dimer forma-
tion decreased and the quantity of monomers increased with
increasingly larger deletions of the TPM3 region from the amino
terminal, and no dimer formation was detected when the entire
length of TPM3 was deleted. When a quarter of the carboxyl region
of TPM3was deleted, a dimer band could still be detected using BN-
PAGE. Thus, no speciﬁc domain within TPM3 was responsible for
dimerization, but the length of TPM3 proportionately inﬂuenced
the extent of the dimerization of the TPM3-ALK fusion protein.Fig. 3. Protein assays. (A) Blue-native polyacrylamide gel electrophoresis (BN-PAGE) detec
monomer decreased with increasingly larger deletions of the TPM3 region. (B) SDS-PAGE
decreased dramatically when the full length of the TPM3 region was deleted.3.3. TPM3-ALK dimer activates downstream signal pathways
Finally, we analyzed the effect of dimerization on downstream
signal pathways using SDS-PAGE with western blotting. Phos-
phorylated ALK was detected in full-length TPM3-ALK transfected
HEK293T cells, but not in HEK293T cells transfected with TPM3-
region-deleted fusion gene. Three signal pathways involving ALK
have been reported: the PI3K/Akt, JAK/STAT, and Raf/MEK/ERK
pathways. Among them, phosphorylation of Akt was similar be-
tween GFP control-transfected and fusion gene-transfected
HEK293T cells (data not shown). Phosphorylation of STAT3 and
ERK1/2 was detected in full-length TPM3-ALK-transfected
HEK293T cells, but not in TPM3-region-deleted or control cells
(Fig. 3). STAT3 and ERK1/2 phosphorylation was also seen in
HEK293T cells transfected with TPM3-ALK fusion genes with
incomplete lengths of the TPM3 region (D1, D2, D3). These results
suggest that the dimerization of TPM3-ALK induces ALK phos-
phorylation and activates the JAK/STAT and Raf/MEK/ERK
pathways.
4. Discussion
In the present study, we visualized the dimerization of the
oncogenic fusion protein TPM3-ALK using BN-PAGE. BN-PAGE is a
native-PAGE technique that was established by Schagger et al. in
1991 [15,16]. Unlike other native PAGE techniques, in which no
charged dye is used, Coomassie Brilliant Blue is used as a charge
shift molecule in BN-PAGE. Therefore, the size resolution of the
technique is as high as that of SDS-PAGEwhile the protein is kept in
its native state [17]. Thus, BN-PAGE is a useful and simple technique
for analyzing the protein complexes. In previous reports, oncogenic
dimerization was demonstrated using a more complicated proce-
dure: Bischof et al. performed coimmunoprecipitation experiments
using anti-ALK and anti-NPM antibodies to detect a heterodimer
between NPM-ALK and wild-type NPM and also performed ated dimer and monomer of the TPM3-ALK fusion protein. The proportion of dimer to
with western blotting revealed that the phosphorylation of ALK, STAT3 and ERK1/2
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assay to reveal a kinase activity in the gradient fraction that was
larger than that for the NPM-ALK monomer [7]; McWhirter et al.
demonstrated oligomerization by applying a glutaraldehyde cross-
linking technique to puriﬁed Bcr peptide, thereby revealing the
presence of Bcr-Abl fusion protein oligomerization [8]. Successful
use of this simple BN-PAGE technique to visualize the dimerization
of an oncogenic fusion genewas to our knowledge for the ﬁrst time.
Overexpression of TPM3-ALK led to phosphorylation of ALK,
STAT3, and ERK1/2 and loss of contact inhibition, whereas phos-
phorylation and focus-forming potential were lost when the full
length of the TPM3 region was deleted. This suggests that over-
expression of ALK alone is not sufﬁcient to activate the ALK
signaling. Although Caren et al. [18] reported that 5% of sporadic
neuroblastomas had exhibited ampliﬁcation of the ALK gene locus
without ALK gene mutation, Soda et al. [19] denied the trans-
forming activity of NIH3T3 cells arising from ALK gene over-
expression alone. Our study revealed again the importance of the
fusion gene partner in the constitutive activation of the oncogenic
signal pathway through the induction of dimerization.
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